An in vitro cytotoxicity of glufosfamide in HepG2 cells relative to its nonconjugated counterpart
Abstract Background Glufosfamide (β-d-glucosylisophosphoramide mustard, GLU) is an alkylating cytotoxic agent in which ifosforamide mustard (IPM) is glycosidically linked to the β-d-glucose molecule. GLU exerted its cytotoxic effect as a targeted chemotherapy. Although, its cytotoxic efficacy in a n...
Main Authors: | Doaa E. Ahmed, Fatma B. Rashidi, Heba K. Abdelhakim, Amr S. Mohamed, Hossam M. M. Arafa |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2021-08-01
|
Series: | Journal of the Egyptian National Cancer Institute |
Subjects: | |
Online Access: | https://doi.org/10.1186/s43046-021-00080-6 |
Similar Items
-
The chemomodulatory effects of glufosfamide on docetaxel cytotoxicity in prostate cancer cells
by: Reem T. Attia, et al.
Published: (2016-06-01) -
Basil and Dracocephalum kotschyi alcoholic extracts affect BCL2 expression and HepG2 cell proliferation
by: Mansour Moghimi, et al.
Published: (2019-02-01) -
A Novel Alkylating Agent, Glufosfamide, Enhances the Activity of Gemcitabine In Vitro, In Vivo
by: W. Steve Ammons, et al.
Published: (2007-08-01) -
Insight into Analysis of Essential Oil from <i>Anisosciadium lanatum</i> Boiss.—Chemical Composition, Molecular Docking, and Mitigation of Hepg2 Cancer Cells through Apoptotic Markers
by: Hany Ezzat Khalil, et al.
Published: (2021-12-01) -
Anti-Inflammatory Effect of Protopine through MAPK and NF-κB Signaling Regulation in HepG2 Cell
by: MinGyu Kim, et al.
Published: (2022-07-01)